Tag: CBC Group
China’s YishengBio eyes US capital markets via SPAC route
Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023
LATEST ON LAW.ASIA
MOST READ ON LAW.ASIA
Governance redefined
Corporate governance is evolving beyond compliance to encompass accountability, sustainability?and long-term value
